Affiliation:
1. Kazan State Medical University
Abstract
The article is devoted to the analysis of the first clinical application of alloplant biomaterial in cardiac surgery for the treatment of congenital heart defects. Alloplant technology— processing of cadaver material— was developed by Professor E.R.Muldashev in the late 1970s for the needs of ophthalmic surgery and has proven itself to be the best. Taking into account the extensive positive experience in ophthalmic surgery, we jointly created an alloplant from the pulmonary artery, aorta, and then from the vena cava for use in the surgical treatment of congenital heart defects, including in children of the first year of life. The article presents the results of treatment of a small group of patients with similar diagnoses and a long follow-up period.
Reference15 articles.
1. Report of the New England Regional Infant Cardiac Program
2. Surgical treatment of aortic coarctation in infants younger than three months: 1985 to 1990
3. Repair of Coarctation of the Aorta in Neonates and Infants: A Thirty-Year Experience
4. Sinelnikov YuS, Kshanovskaya MS, Prokhorova DS, Nartsissova GP, Gorbatych AV, Ivanzov SM, Soinov IA, Kornilov IA. Surgical correction of aortic coarctation: does it always satisfy expectation? Siberian journal of clinical and experimental medicine. 2013;28(4):55–58. (In Russ.) EDN: UDEGMT
5. Mirolyubov LM, Nurmeev IN. Vrozhdyonnye poroki serdtsa. Diagnostika i lechenie. (Congenital heart defects. Diagnosis and treatment.) Kazan: Brig; 2020. 103 p. (In Russ.)